Miglitol 25 MG Oral Tablet — RxCUI 205329
RxNorm drug concept · Semantic clinical drug
RxCUI 205329
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
15 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI205329
Official nameMiglitol 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped6
Package NDCs mapped15
Reported Medicaid activity (SDUD)52 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Miglitol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Miglitol helps adults with type 2 diabetes control blood sugar, alongside diet and exercise. It works in your gut to slow how fast carbs turn into sugar. You can take it alone or w...
- Take it three times a day at the start of each main meal. Your prescriber will likely start you low and raise the dose slowly to help your stomach adjust. Follow your label for you...
- Because it slows carb digestion, some carbs reach your lower gut and cause gas, diarrhea and belly pain. These are the most common effects and often ease over time. Call your docto...
- Why does miglitol give me gas and diarrhea?
🕸️ Concept Web — How Miglitol 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Miglitol 25 MG Oral Tablet
RxCUI 205329 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Miglitol
30009IN
-
Miglitol
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Miglitol Oral Tablet
372926SCDF -
Miglitol Oral Product
1157268SCDG -
Miglitol Pill
1157269SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Miglitol Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Miglitol 25 MG
316305SCDC
-
Miglitol 25 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Miglitol 25 MG
SCDC · 316305 -
Miglitol Oral Tablet
SCDF · 372926 -
Miglitol Oral Product
SCDG · 1157268 -
Miglitol Pill
SCDG · 1157269
📦 FDA Products & Package NDCs
6 products · 15 package NDCs
15 package NDCs map to RxCUI 205329 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69367-0303-01 | 100 TABLET, COATED in 1 BOTTLE (69367-303-01) | Miglitol | Westminster Pharmaceuticals, LLC | 2021-01-15 |
| 69367-0304-01 | 100 TABLET, COATED in 1 BOTTLE (69367-304-01) | Miglitol | Westminster Pharmaceuticals, LLC | 2021-01-15 |
| 69367-0305-01 | 100 TABLET, COATED in 1 BOTTLE (69367-305-01) | Miglitol | Westminster Pharmaceuticals, LLC | 2021-01-15 |
| 71205-0935-00 | 100 TABLET, COATED in 1 BOTTLE (71205-935-00) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0935-30 | 30 TABLET, COATED in 1 BOTTLE (71205-935-30) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0935-60 | 60 TABLET, COATED in 1 BOTTLE (71205-935-60) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0935-90 | 90 TABLET, COATED in 1 BOTTLE (71205-935-90) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0936-00 | 100 TABLET, COATED in 1 BOTTLE (71205-936-00) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0936-30 | 30 TABLET, COATED in 1 BOTTLE (71205-936-30) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0936-60 | 60 TABLET, COATED in 1 BOTTLE (71205-936-60) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0936-90 | 90 TABLET, COATED in 1 BOTTLE (71205-936-90) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0937-00 | 100 TABLET, COATED in 1 BOTTLE (71205-937-00) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0937-30 | 30 TABLET, COATED in 1 BOTTLE (71205-937-30) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0937-60 | 60 TABLET, COATED in 1 BOTTLE (71205-937-60) | Miglitol | Proficient Rx LP | 2021-03-01 |
| 71205-0937-90 | 90 TABLET, COATED in 1 BOTTLE (71205-937-90) | Miglitol | Proficient Rx LP | 2021-03-01 |
Observed labelers:
Proficient Rx LP (12) ·
Westminster Pharmaceuticals, LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.